IDEXX LABORATORIES INC /DE - Common Stock (IDXX)

Q2 2025 13F Holders as of 6/30/2025

Type / Class
Equity / Common Stock
Shares outstanding
80.8M
Number of holders
1214
Total 13F shares, excl. options
74.3M
Shares change
+1M
Total reported value, excl. options
$39.9B
Value change
+$624M
Put/Call ratio
1.27
Number of buys
597
Number of sells
-505
Price
$536.34

Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2025

1,342 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2025.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 74.3M shares of 80.8M outstanding shares and own 91.93% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.88M shares), BlackRock, Inc. (8.37M shares), STATE STREET CORP (3.55M shares), Fundsmith LLP (2.64M shares), GEODE CAPITAL MANAGEMENT, LLC (2.46M shares), BAMCO INC /NY/ (2.03M shares), MORGAN STANLEY (1.66M shares), Bank of New York Mellon Corp (1.45M shares), POLEN CAPITAL MANAGEMENT LLC (1.2M shares), and Invesco Ltd. (1.16M shares).
This table shows the top 1214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.